Stocks

Stocks
Stocks

Is Beiersdorf stock a buy after 44% crash? UBS upgrade offers key signals

Beiersdorf stock’s long slump has finally been enough to make one major broker step back from its bearish stance. UBS upgraded the German skincare and consumer-goods group to “neutral” from “sell” on Tuesday. The analysts argued that after a two-year share-price slide, the valuation now looks far less demanding. But the move was hardly a

Read More
Stocks

SCHD ETF dividend yield too low? Top 3 alternatives to consider

The Schwab US Dividend Equity ETF (SCHD) has accumulated over $83 billion in assets, making it one of the biggest dividend funds in the United States.  SCHD ETF main limitation is its low dividend yield  This growth has been driven by the ongoing rotation from growth to value, and the fact that it has a

Read More
Stocks

Bulgaria to launch first EU support scheme for energy-heavy industry

Bulgaria is poised to become the first European Union member state to introduce a dedicated support scheme for energy-intensive industries, aiming to shield firms from elevated power costs stemming from the energy crisis triggered by the war in Iran. Energy Minister Traicho Traikov said the programme is in the final stage of European Commission approval

Read More
Stocks

Nebius stock gains 4.5% on plans to build $10B Finland data centre

AI infrastructure firm Nebius Group is accelerating its push into Europe with plans to develop a 310-megawatt data centre in Finland. The Amsterdam-based company stated that the facility, situated in Lappeenranta near the Russian border, is being developed by its Finnish partner, Polarnode, and is expected to come online in phases starting in 2027. Valued

Read More
Stocks

Novo cuts Ozempic, Wegovy prices up to 48% as generics surge

Novo Nordisk cut prices for its diabetes and weight-loss injections Ozempic and Wegovy in India on Tuesday, marking a second reduction aimed at countering cheaper local generics. The company lowered list prices by up to 36% for Ozempic and up to 48% for Wegovy, with the move following the March 20 expiry of India’s patent

Read More
Stocks

Dow Jones jumps 380 points as Iran de-escalation hopes lift stocks

US stocks rose on Tuesday, as investors responded positively to signs of potential de-escalation in the Middle East conflict, even as oil prices remained elevated and broader market risks persisted. The Dow Jones Industrial Average climbed 380 points or 0.8%, while the S&P 500 and Nasdaq 100 also advanced more than 1%. The gains followed

Read More
Stocks

Barclays names top 4 defensive stocks to weather global uncertainty

As Dow Jones slides into the “correction territory” and the benchmark S&P 500 index logs its fifth consecutive week of losses, investors are increasingly desperate for a port in the storm. According to Barclays’ senior analyst Andrew Ferremi, the market has shifted into a new, volatile era where geopolitical tensions, oil price spikes, and AI-driven

Read More
Stocks

As US tech stocks fall on AI and war fears, are valuations attractive now?

US megacap technology stocks, long the driving force behind a bull run spanning more than three years, are undergoing a sharp valuation reset as a mix of geopolitical tensions, rising yields, and questions around artificial intelligence spending weigh on sentiment. The pullback has intensified in recent weeks, with the sector already under pressure before the

Read More
Stocks

Nvidia just invested in Marvell stock: should you too?

Marvell Technology Inc (NASDAQ: MRVL) is inching higher after Nvidia announced a [MONEY value="2000000000" currency="usd" notation="long" replace="false"] direct investment and a strategic partnership with the custom chips specialist. MRVL pushed past its 20-day moving average (MA) today as investors reacted to this monumental vote of confidence that will see NVDA integrate the firm’s tech into

Read More
Stocks

US banks raise costs for private credit funds as valuation fears grow: report

US banks are raising borrowing costs for some loans to private credit funds amid growing concerns over valuations, a shift that could pressure returns and curb new lending, according to a Reuters report. The higher pricing is showing up in back leverage facilities tied to business development companies, or BDCs, reversing a period of compressing

Read More